Boston/HK-based AI biotech Insilico Medicine released industry benchmarks—demonstrating an average 13-month timeline to preclinical drug candidate nomination, a reduction from the traditional 2.5- to 4-year process.
Post image

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service